1. Goldenthal, M.J., Mitochondrial involvement in myocyte death and heart failure, Heart Fail. Rev., 2016, vol. 21, pp. 137–155.
2. Mironkov, A.B., Myocardial revascularization in treatment of patients with systemic left ventricular dysfunction: the state of the problem, Vestn. Transplant. Iskusstv. Organs, 2013, vol. 15, no. 2, pp. 156–163.
3. Coetzee, W.A., Multiplicity of effectors of the cardioprotective agent, diazoxide, Pharmacol. Ther., 2013, vol. 140, pp. 167–175.
4. Henn, M.C., Janjua, M.B., Kanter, E.M., Makepeace, C.M., Schuessler, R.B., Nichols, C.G., and Lawton, J.S., Adenosine triphosphate-sensitive potassium channel Kir subunits implicated in cardioprotection by diazoxide, J. Amer. Heart Assoc., 2015, vol. 4, p. e002016.
5. Korotkov, S.M., Emelyanova, L.V., Brailovskaya, I.V., and Nesterov, V.P., The effect of pinacidil and calcium on isolated rat heart mitochondria, Dokl. Akad. Nauk, 2012, vol. 443, no. 5, pp. 632–636.